SLC25A22 and cancer: Meanwhile, the gene level of matrix metallopeptidase nine and tumor necrosis factor α related to tumor metastasis exhibits a downward trend in SLC25A22-silenced cancer cells, indicating inhibition of GSH synthesis may play a critical role in the treatment of cancer metastasis (Wong et al., 2016).